Show simple item record

Morphology of gastrointestinal stromal tumors: Historical perspectives

dc.contributor.authorAppelman, Henry D.en_US
dc.date.accessioned2011-12-05T18:33:38Z
dc.date.available2013-02-01T20:26:18Zen_US
dc.date.issued2011-12en_US
dc.identifier.citationAppelman, Henry D. (2011). "Morphology of gastrointestinal stromal tumors: Historical perspectives." Journal of Surgical Oncology 104(8): 874-881. <http://hdl.handle.net/2027.42/88063>en_US
dc.identifier.issn0022-4790en_US
dc.identifier.issn1096-9098en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/88063
dc.description.abstractAbout 2/3 of gastrointestinal stromal tumors occur in the stomach and about 1/5 in the small intestine with few in the rectum, colon, and esophagus. Their cells are related to the interstitial cells of Cajal. They differ by site in terms of cell type and growth pattern. Benign and malignant tumors are separated based on their light microscopic appearances, size as measured by innumerable pathologists and assistants and mitotic counts. J. Surg. Oncol. 2011; 104:874–881. © 2011 Wiley Periodicals, Inc.en_US
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.subject.otherStromal Tumorsen_US
dc.subject.otherDifferentiationen_US
dc.subject.otherMalignant Featuresen_US
dc.subject.otherFrozen Section Diagnosisen_US
dc.titleMorphology of gastrointestinal stromal tumors: Historical perspectivesen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbsecondlevelSurgery and Anesthesiologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumM.R. Abell Professor of Surgical Pathology, Department of Pathology, University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationumDepartment of Pathology, University of Michigan, 1301 Catherine Street, Ann Arbor, MI 48109‐5602. Fax: 734‐615‐8340en_US
dc.identifier.pmid22069172en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/88063/1/21873_ftp.pdf
dc.identifier.doi10.1002/jso.21873en_US
dc.identifier.sourceJournal of Surgical Oncologyen_US
dc.identifier.citedreferenceAppelman HD: Mesenchymal tumors of the gastrointestinal tract. In: Ming SC, Goldman H, editors. Pathology of the gastrointestinal tract, 2nd edition. Baltimore: Williams & Wilkins; 1998. pp. 361 – 398.en_US
dc.identifier.citedreferenceAppelman HD: Smooth muscle tumors of the gastrointestinal tract. What we know now that Stout didn't know. Am J Surg Pathol 1986; 10: 83 – 99.en_US
dc.identifier.citedreferenceGolden T, Stout AP: Smooth muscle tumors of the gastrointestinal tract and retroperitoneal tissues. Surg Gynecol Obstet 1941; 73: 784 – 810.en_US
dc.identifier.citedreferenceStout AP: Tumors of the stomach. Atlas of tumor pathology, section 6, fascicle 21. Washington, DC: Armed Forces Institute of Pathology; 1953.en_US
dc.identifier.citedreferenceAppelman HD, Helwig EB: Cellular leiomyomas of the stomach in 49 patients. Arch Pathol Lab Med 1977; 101: 373 – 377.en_US
dc.identifier.citedreferenceAppelman HD, Helwig EB: Gastric epithelioid leiomyoma and leiomyosarcoma (leiomyoblastoma). Cancer 1976; 38: 708 – 728.en_US
dc.identifier.citedreferenceAkwari OE, Dozois RR, Weiland LH, et al.: Leiomyosarcoma of the small and large bowel. Cancer 1978; 42: 1375 – 1384.en_US
dc.identifier.citedreferenceChiotasso PJ, Fazio VW: Prognostic factors of 28 leiomyosarcomas of the small intestine. Surg Gynecol Obstet 1982; 155: 197 – 202.en_US
dc.identifier.citedreferenceLindsay PC, Ordonez N, Raaf JH: Gastric leiomyosarcomas: Clinical and pathological review of fifty patients. J Surg Oncol 1981; 18: 399 – 421.en_US
dc.identifier.citedreferenceRanchod M, Kempson RL: Smooth muscle tumors of the gastrointestinal tract and retroperitoneum. Cancer 1977; 39: 255 – 262.en_US
dc.identifier.citedreferenceShiu MH, Farr GH, Papachristou DN, et al.: Myosarcomas of the stomach: Natural history, prognostic factors and management. Cancer 1982; 49: 177 – 187.en_US
dc.identifier.citedreferenceSaul SH, Rast ML, Brooks JJ: The immunohistochemistry of gastrointestinal stromal tumors. Evidence supporting origin from smooth muscle. Am J Surg Pathol 1987; 11: 464 – 473.en_US
dc.identifier.citedreferenceSarlomo‐Rikala M, Kovatich AJ, Barusevicius A, et al.: CD117: A sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 1998; 11: 728 – 734.en_US
dc.identifier.citedreferenceMiettinen M, Sarlomo‐Rikala M, Lasota J: Gastrointestinal stromal tumors: Recent advances in understanding of their biology. Hum Pathol 1999; 30: 1213 – 1220.en_US
dc.identifier.citedreferenceMiettinen M, Sobin LH, Sarlomo‐Rikala M: Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT). Mod Pathol 2000; 13: 1134 – 1142.en_US
dc.identifier.citedreferenceMiettinen M, Lasota J: Gastrointestinal stromal tumors. Review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med 2006; 130: 1466 – 1478.en_US
dc.identifier.citedreferenceMiettinen M, Sarlomo‐Rikala M, Sobin LH, et al.: Esophageal stromal tumors. A clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas. Am J Surg Pathol 2000; 24: 211 – 212.en_US
dc.identifier.citedreferenceLasota J, Dansonka‐Mieszkowska A, Sobin LH, et al.: A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential. Lab Invest 2004; 84: 874 – 883.en_US
dc.identifier.citedreferenceMiettinen M, Sobin LH, Lasota J: Gastrointestinal stromal tumors of the stomach. A clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long‐term follow‐up. Am J Surg Pathol 2005; 29: 52 – 68.en_US
dc.identifier.citedreferenceMiettinen M, Kopczynski J, Makhlouf HR, et al.: Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum. A clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases. Am J Surg Pathol 2003; 27: 625 – 641.en_US
dc.identifier.citedreferenceMiettinen M, Makhlouf H, Sobin LH, et al.: Gastriintestinal stromal tumors of the jejunum and ileum. A clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long‐term follow‐up. (Skeinoid fibers are good and epithelioid cells are bad prognosticators).en_US
dc.identifier.citedreferenceMiettinen M, Sarlomo‐Rikala M, Sobin LH, et al.: Gastrointestinal stromal tumors and leiomyosarcomas in the colon. A clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases. Am J Surg Pathol 2000; 24: 1339 – 1352.en_US
dc.identifier.citedreferenceMiettinen M, Sobin LH: Gastrointestinal stromal tumors of the appendix. A clinicopathologic and immunohistochemical study of four cases. Am J Surg Pathol 2001; 25: 1433 – 1437.en_US
dc.identifier.citedreferenceMiettinen M, Furlong M, Sarlomo‐Rikala M, et al.: Gastrointestinal stromal tumors, intramural leiomyomas, and l.: A clinicopathol: Immunohistochemical, and molecular genetic study of 144 cases. Am J Surg Pathol 2001; 25: 1121 – 1133.en_US
dc.identifier.citedreferenceMartin JF, Bazin P, Feroldi J, et al.: Tumeurs myoides intra‐murales de l'estomac: Considerations microscopiques a propos de 6 cas. Ann Anat Pathol (Paris) 1960; 5: 484 – 497.en_US
dc.identifier.citedreferenceStout AP: Bizarre smooth muscle tumors of the stomach. Cancer 1962; 15: 400 – 409.en_US
dc.identifier.citedreferenceWelsh RA, Meyer AT: Ultrastructure of the gastric leiomyoma. Arch Pathol 1969; 87: 71 – 81.en_US
dc.identifier.citedreferenceCornog JL: Gastric leiomyoblastoma. A clinical and ultra‐structural study. Cancer 1974; 34: 711 – 719.en_US
dc.identifier.citedreferenceAppelman HD: Stromal tumors of the esophagus, stomach and duodenum. In: Appelman HD, editor. Pathology of the esophagus, stomach and duodenum. (Contemporary issues in surgical pathology.) New York: Churchill Livingston; 1984.en_US
dc.identifier.citedreferenceMazur MT, Clark HB: Gastric stromal tumors: Reappraisal of histogenesis. Am J Surg Pathol 1983; 7: 507 – 519.en_US
dc.identifier.citedreferenceKnapp RH, Wick MR, Goellner JR: Leiomyoblastomas and their relationship to other smooth muscle tumors of the gastrointestinal tract. Am J Surg Pathol 1984; 8: 449 – 461.en_US
dc.identifier.citedreferenceSchaldenbrand JD, Appelman HD: Solitary solid stromal gastrointestinal tumors in von Recklinghausen's disease with minimal smooth muscle differentiation. Hum Pathol 1984; 15: 229 – 232.en_US
dc.identifier.citedreferenceWalker P, Dvorak AM: Gastrointestinal autonomic nerve (GAN) tumor. Ultrastructural evidence for a newly recognized entity. Arch Pathol Lab Med 1986; 110: 309 – 316.en_US
dc.identifier.citedreferenceKIindblom L‐G, Remotti HE, Aldenberorg F, et al.: Gastrointestinal pacemaker cell tumor (GIPACT). Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 1998; 152: 1259 – 1269.en_US
dc.identifier.citedreferenceLee JR, Joshi V, Griffin JW, Jr., et al.: Gastrointestinal autonomic nerve tumor. Immunohistochemical and molecular identity with gastrointestinal stromal. Am J Surg Pathol 2001; 25: 979 – 987.en_US
dc.identifier.citedreferenceDebiec‐Rychter M, Pauwels P, Lasota J, et al.: Complex genetic alterations in gastrointestinal stromal tumors with autonomic nerve differentiation. Mod Pathol 2002; 15: 692 – 698.en_US
dc.identifier.citedreferencePike AM, Lloyd RV, Appelman HD: Cell markers in gastrointestinal stromal tumors. Hum Pathol 1988; 19: 830 – 834.en_US
dc.identifier.citedreferenceHorota S, Isozaki K, Moriyama Y, et al.: Gain‐of‐function mutations of c‐kit in human gastrointestinal stromal tumors. Science 1998; 279: 577 – 580.en_US
dc.identifier.citedreferenceSircar K, Hewlett BR, Huizinga JD, et al.: Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors. Am J Surg Pathol 1999; 23: 377 – 389.en_US
dc.identifier.citedreferenceSeidal T, Edvardsson H: Expression of c‐kit (CD117) and Ki67 provides information about the possible cell of origin and clinical course of gastrointestinal stromal tumors. Histopathology 1999; 34: 416 – 424.en_US
dc.identifier.citedreferenceFletcher CDM, Berman JJ, Corless C, et al.: Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 2002; 33: 459 – 495.en_US
dc.identifier.citedreferenceHornick JL, Fletcher CDM: The role of KIT in the management of patients with gastrointestinal stromal tumors. Hum Pathol 2007; 38: 679 – 687.en_US
dc.identifier.citedreferenceAgaimy A, Sunch PH, Hofstaedter F, et al.: Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c‐KIT mutations. Am J Surg Pathol 2007; 31: 113 – 120.en_US
dc.identifier.citedreferenceLewin KJ, Appelman HD: Mesenchymal tumors and tumor‐like proliferations (of the stomach). in tumors of the esophagus and stomach, fascicle 18, atlas of tumor pathology, Third Series, Armed Forces Institute of Pathology, Washington, DC, 1996: 405–456. This summarizes almost everything that was known about GASTs up to the time of last revision which was late 1994.en_US
dc.identifier.citedreferenceTrupiano JK, Stewart RE, Misick C, et al.: Gastric stromal tumors. A clinicopathologic study of 77 cases with correlation of features with nonaggressive and aggressive clinical behaviors. Am J Surg Pathol 2002; 26: 705 – 714.en_US
dc.identifier.citedreferenceCarney JA: The triad of gastric epithelioid leiomyosarcoma, pulmonary chondroma, and functioning extra‐adrenal paraganglioma: A five‐year review. Medicine 1983; 62: 159 – 169.en_US
dc.identifier.citedreferenceCarney JA: Gastric stromal sarcoma, pulmonary chondroma, and extra‐adrenal paraganglioma (Caraney triad): Natural history, adrenocortical component, and possible familial occurrence. Mayo Clin Proc 1999; 74: 543 – 552.en_US
dc.identifier.citedreferenceGoldblum JR, Appelman HD: Stromal tumors of the duodenum. A histologic and immunohistochemical study of 20 cases. Am J Surg Pathol 1995; 19: 71 – 80.en_US
dc.identifier.citedreferenceBrainard JA, Goldblum JR: Stromal tumors of the jejunum and ileum. A clinicopathologic study of 39 cases. Am J Surg Pathol 1997; 21: 407 – 416.en_US
dc.identifier.citedreferenceMa CK, De Peralta MN, Amin MB, et al.: Small intestinal stromal tumors. A clinico‐pathologic study of 20 cases with immunohistochemical assessment of cell differentiation and the prognostic rose of proliferation antigens. Am J Clin Pathol 1997; 108: 641 – 651.en_US
dc.identifier.citedreferenceTworek JA, Appelman HD, Singleton TP, et al.: Stromal tumors of the jejunum and ileum. Mod Pathol 1997; 10: 200 – 209.en_US
dc.identifier.citedreferenceTworek JA, Goldblum JR, Weiss SW, et al.: Stromal tumors of the abdominal colon. A clinicopathologic study of 20 cases. Am J Surg Pathol 1999; 23: 937 – 945.en_US
dc.identifier.citedreferenceWalsh TH, Mann CV: Smooth muscle neoplasms of the rectum and anal canal. Br J Surg 1984; 71: 597 – 599.en_US
dc.identifier.citedreferenceHaque S, Dean PJ: Stromal neoplasms of the rectum and anal canal. Hum Pathol 1992; 23: 762 – 767.en_US
dc.identifier.citedreferenceMeijer S, Peretz T, Gaynor JJ, et al.: Primary colorectal sarcoma. A retrospective review and prognostic factor study of 50 consecutive cases. Arch Surg 1990; 125: 1163 – 1168.en_US
dc.identifier.citedreferenceTjandra JJ, Antoniuk PM, Webb B, et al.: Leiomyosarcoma of the rectum and anal canal. Aust N Z J Surg 1993; 63: 703 – 709.en_US
dc.identifier.citedreferenceTworek JA, Goldblum JR, Weiss SW, et al.: Stromal tumors of the anorectum. A clinicopathologic study of 22 cases. Am J Surg Pathol 1999; 23: 946 – 954.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.